News & Analysis on Clinical Trial Services & Contract Research And Development
A shortage of Clinical Research Associates (CRAs) is fuelling the “war on talent” among CROs according to an ex-monitor, who says a pre-hire simulation service can turn focus from retention to creation of staff.
Roche’s exit from four small molecule manufacturing plants will provide opportunities for third-party manufacturers, the firm says.
Specialised drugs made using flexible technologies are the future for Roche’s small molecule portfolio, the firm says as it restructures its production network.